Inactivation of one Ptc1 allele predisposes humans and mice to spontaneous medulloblastoma development, and irradiation of newborn Ptc1 heterozygous mice results in dramatic increase of medulloblastoma incidence. While a role for loss of wild-type (wt) Ptc1 (LOH) in radiationinduced medulloblastomas from Ptc1 neo67/ þ mice is well established, the importance of this event in spontaneous medulloblastomas is still unclear. Here, we demonstrate that biallelic Ptc1 loss plays a crucial role in spontaneous medulloblastomas, as shown by high rate of wt Ptc1 loss in spontaneous tumors. In addition, remarkable differences in chromosomal events involving the Ptc1 locus in spontaneous and radiation-induced medulloblastomas suggest distinct mechanisms for Ptc1 loss. To assess when, during tumorigenesis, Ptc1 loss occurs, we characterized cerebellar abnormalities that precede tumor appearance in Ptc1 neo67/ þ mice. We show that inactivation of only one copy of Ptc1 is sufficient to give rise to abnormal cerebellar proliferations with different degree of altered cell morphology, but lacking potential to progress to neoplasia. Furthermore, we identify biallelic Ptc1 loss as the event causally related to the transition from the preneoplastic stage to full blown medulloblastoma. These results underscore the utility of the Ptc1 neo67/ þ mouse model for studies on the mechanisms of medulloblastoma and for development of new therapeutic strategies.
Inactivation of one Ptc1 allele predisposes humans and mice to spontaneous medulloblastoma development, and irradiation of newborn Ptc1 heterozygous mice results in dramatic increase of medulloblastoma incidence. While a role for loss of wild-type (wt) Ptc1 (LOH) in radiationinduced medulloblastomas from Ptc1 neo67/ þ mice is well established, the importance of this event in spontaneous medulloblastomas is still unclear. Here, we demonstrate that biallelic Ptc1 loss plays a crucial role in spontaneous medulloblastomas, as shown by high rate of wt Ptc1 loss in spontaneous tumors. In addition, remarkable differences in chromosomal events involving the Ptc1 locus in spontaneous and radiation-induced medulloblastomas suggest distinct mechanisms for Ptc1 loss. To assess when, during tumorigenesis, Ptc1 loss occurs, we characterized cerebellar abnormalities that precede tumor appearance in Ptc1 neo67/ þ mice. We show that inactivation of only one copy of Ptc1 is sufficient to give rise to abnormal cerebellar proliferations with different degree of altered cell morphology, but lacking potential to progress to neoplasia. Furthermore, we identify biallelic Ptc1 loss as the event causally related to the transition from the preneoplastic stage to full blown medulloblastoma. These results underscore the utility of the Ptc1 neo67/ þ mouse model for studies on the mechanisms of medulloblastoma and for development of new therapeutic strategies. Keywords: medulloblastoma; preneoplasia; Patched; hedgehog; ionizing radiation; LOH Medulloblastoma is a primitive neuroectodermal tumor that develops in the cerebellum, and represents the most common brain tumor of childhood (Packer et al., 1999; Chintagumpala et al., 2001) . Although the cell of origin is still unknown, medulloblastoma is believed to arise from the cerebellar granule neuron precursors (CGNPs), which undergo massive proliferation and migration in response to Sonic Hedgehog (Shh) secreted by Purkinje neurons immediately after birth (Dahmane and Ruiz-iAltaba, 1999; Wallace, 1999) . The Shh pathway is, in fact, a major regulator of cerebellar development. Shh signalling occurs through the interaction of the Shh ligand with its receptor Patched (Ptc1), which causes derepression of Smo and transcription of target genes. A subset of sporadic medulloblastomas (10-25%) has been shown to host mutations causing increased activity of the Shh-Patched pathway (Corcoran and Scott, 2001; Eberhart and Burger, 2003) .
Germ-line mutation of Ptc1 is responsible for the hereditary cancer predisposition syndrome -nevoid basal cell carcinoma syndrome (NBCCS) -in which patients are predisposed to medulloblastoma development (Johnson et al., 1996) . Analogously, mice heterozygous for mutation in Ptc1 develop cerebellar tumors resembling human medulloblastoma (Goodrich et al., 1997; Hahn et al., 1998) . We have shown that irradiation of Ptc1 neo67/ þ mice in neonatal age, when the external granule layer (EGL) is still proliferating in response to the potent mitogenic stimulus of Shh, greatly enhances medulloblastoma incidence (Pazzaglia et al., 2002 . In addition, a crucial role of complete Ptc1 inactivation was established in radiation-induced medulloblastomas.
The importance of biallelic Ptc1 loss in spontaneous medulloblastoma, however, is still controversial; while it was initially proposed that loss of one Ptc1 allele was sufficient for medulloblastoma formation in mice (Wetmore et al., 2000; Zurawel et al., 2000) , mounting evidences suggest that Ptc1 expression is drastically reduced or lacking in Ptc1-associated medulloblastoma (Berman et al., 2002; Pazzaglia et al., 2002; Oliver et al., 2005; Uziel et al., 2005) . To investigate this point further, we examined allelic imbalance at the Ptc1 locus in spontaneous medulloblastomas from Ptc1 neo67/ þ mice. By exploiting a polymorphism (T/C) at position 4016 of the Ptc1 gene (Wetmore et al., 2000) , we show the presence of the 129Sv-derived mutant allele, and lack of the CD1-derived wild-type (wt) allele in six of seven spontaneous medulloblastomas analysed. These results, in close agreement with previous findings of Ptc1 LOH in virtually all radiation-induced medulloblastomas (Pazzaglia et al., 2002) , underscore the role of 'second hit' Ptc1 gene deletions in medulloblastoma development, and confirm that Ptc1 is not haploinsufficient for medulloblastoma suppression, as similarly shown for Ptc1-associated murine basal cell carcinomas (Aszterbaum et al., 1999; Mancuso et al., 2004) . To ascertain that the discrepancy between our (Pazzaglia et al., 2002 and previous results (Wetmore et al., 2000; Zurawel et al., 2000) was not dependent on the genetic background hosting the Ptc1 mutation (Shoemaker et al., 1998) , we also examined spontaneous medulloblastomas from Ptc1 neo67/ þ mice on C57BL/6 background. Ptc1 LOH was detected in six of eight tumors from these mice, indicating that genetic events at the Ptc1 locus are not influenced by genetic background.
To gain insights into the mechanisms of loss of the normal remaining Ptc1 allele, four spontaneous and six radiation-induced medulloblastomas were analysed using a minimum of 16 informative microsatellite markers spanning mouse chromosome 13. We show Figure 1 Analysis of chromosome-13 LOH in spontaneous and radiation-induced medulloblastomas from Ptc1 neo67/ þ mice. The distance of microsatellite markers (D13Mit) from the centromere is given in cM, with values taken from the Genetic and Physical Maps of the Mouse Genome (1999). Solid circles indicate no loss of polymerase chain reaction (PCR) signal from either allele; open circles denote loss of signal from one allele (LOH); grey circles indicate not informative (NI) markers. Polymerase chain reaction primers for chromosome-13 markers were purchased from Research Genetics (Huntsville, AL, USA). Mice used in this study were genetically heterogeneous, thus, we had to test polymorphism for each microsatellite marker. A typical PCR experiment involved analysis of DNAs from tumors and corresponding genomic DNAs from normal tissues as control. Polymerase chain reaction amplifications were performed as described previously (Pazzaglia et al., 2000) .
Biallelic Ptc1 loss and medulloblastoma progression S Pazzaglia et al that whole-chromosome loss did not occur in spontaneous or radiation-induced tumors (Figure 1 ), thus excluding nondisjunction or loss and reduplication of the whole chromosome as a mechanism for Ptc1 loss. All medulloblastomas, instead, had LOH with variable extension. In addition, our data show the absence of highly stringent breakpoint clustering, consistent with a genetic mechanism based on loss of a critical gene within the chromosome-13 minimal deleted region, where Ptc1 is located. Interestingly, our results show that the pattern of LOH in radiation-induced medulloblastomas may be distinguished from that observed in spontaneous tumors. We show that, while in spontaneous tumors Ptc1 LOH occurs through loss of most chromosome-13 distal region (X34 cM), with only the most proximal markers retained, all tumors presenting in irradiated animals had interstitial chomosome-13 losses, with LOH encompassing a region of 2-20 cM ( Figure 1 ). Consistent with the low probability of two simultaneous breaks in unexposed cells, the presence of terminal deletions as opposed to lack of chromosome-13 interstitial losses in spontaneous medulloblastomas suggests the predominance of single events, that is, involving only one breakpoint. Instead, the prevalence of relatively small interstitial deletions (o40% of chromosome length) in radiation-induced medulloblastomas, requiring two close breaks for their generation, is coherent with the mechanism of action of ionizing radiation. Interstitial deletions have, in fact, been reported to be a signature mutation for ionizing-radiation mutagenesis (Hutchinson, 1995; Nelson et al., 1995; Yamada et al., 1996; Turker et al., 1997) . These results strongly suggest that wt Ptc1 loss is common to both spontaneous and radiation-induced medulloblastoma in Ptc1 heterozygotes, but that different molecular mechanisms underlie this loss. A further interesting outcome of this study is the presence of additional chromosome-13 LOH events, apparently unlinked to the deletion causing Ptc1 LOH, in radiation-induced medulloblastomas. Three of six tumors in which wt Ptc1 was lost showed these additional deletion events (Figure 1) . Interestingly, discontinuous LOH mutational patterns have been proposed as a novel signature for delayed mutagenic effects caused by ionizing radiation through induction of genomic instability (Ponomareva et al., 2002) . These results suggest that LOH events are triggered by ionizing radiation either through direct damage or delayed genomic instability.
Although the importance of LOH events for the inactivation of tumor suppressor genes in sporadic and heritable cancer is well established (Knudson, 1971 (Knudson, , 1993 Kinzler and Vogelstein, 1997) , it is still unclear whether such events are involved in the initiation of tumorigenesis or are a consequence of the general genetic instability acquired during tumor development. The involvement of LOH in the initiation of tumorigenesis can only be established analyzing preneoplastic stages. One remarkable feature of Ptc1-associated medulloblastoma is development through microscopically recognizable preneoplastic lesions, which allows investigation of early genetic events in tumor development. Cerebellar abnormalities that precede medulloblastoma appearance in Ptc1 þ /À mice were recently reported by several groups, including ours (Goodrich et al., 1997; Corcoran and Scott 2001; Kim et al., 2003; Pazzaglia, 2006) . Lack of information regarding the nature and sequence of events leading to progression of medulloblastoma preneoplasia prompted us to study this issue in depth.
To evaluate progression of preneoplastic areas, large cohorts of untreated Ptc1 neo67/ þ heterozygotes (n ¼ 66) were killed at progressive time points from 2 to 9 weeks of age and their cerebellar pathology was assessed. As we described previously (Pazzaglia, 2006; Pazzaglia et al., 2006) , abnormal cerebellar regions with morphology varying from focal subpial aggregates of CGNPs to overt nodules are evident by histological examination of cerebella from asymptomatic Ptc1 mutants. We show here that the frequency of these lesions is strongly influenced by mouse age (Figure 2 ). At 2-3 weeks of age, preneoplastic areas were evident in 52.6% (10/19) of Ptc1 neo67/ þ mice. With increasing age, this frequency decreased, being 35.3% (6/17) in mice of 4-5 weeks, and 35.7% (5/14) in mice of 6-7 weeks. Notably, such cerebellar abnormalities completely regressed at later times, and were no longer observed in mice of 8-9 weeks (n ¼ 16). Regression phenomena are fully consistent with the finding that only 7% of unirradiated Ptc1 heterozygous mice will eventually develop medulloblastoma (Pazzaglia et al., 2002) . The hypothesis that cerebellar lesions may represent a pool of vulnerable CGNPsalthough capable of full regression without additional mutations conferring further proliferative advantagehas been originally formulated by Kim et al. (2003) . Nevertheless, the molecular event cooperating with Ptc1 Figure 2 Incidence of microscopic cerebellar lesions in control (n ¼ 66) and neonatally irradiated (3 Gy X-ray at P1, n ¼ 54) Ptc1 neo67/ þ mice. Mice were killed at progressive time points from 2 to 9 weeks of age. Cerebella were fixed in 4% buffered formalin, embedded in paraffin, sectioned and stained with H&E. Twentyfour sections were examined for each cerebellum. To ensure representative sampling, each set of sections (n ¼ 8) in an individual slide was recovered with an interval of 70 mm. The incidence of preneoplastic lesions was expressed as the percentage of mice with one or more abnormal cerebellar regions in the EGL. Mice were exposed to a single dose of 3 Gy of X-ray. Irradiation was performed using a Gilardoni CHF 320 G X-ray generator (Gilardoni S.p.A., Mandello del Lario, Lecco, Italy) operated at 250 kVp, 15 mA, with filters of 2.0 mm Al and 0.5 mm Cu. heterozygosity to promote the malignant phenotype in a subset of Ptc1 mutants was not identified.
We have recently shown that a drastic increase in medulloblastoma incidence (over 10-fold) can be induced by complementing Ptc1 mutation with ionizingradiation exposure in neonatal age . In this study, to facilitate investigation of the steps involved in malignant progression of early cerebellar lesions, we exposed Ptc1 þ /À newborns (n ¼ 54) to ionizing radiation (3 Gy of X-rays) at postnatal day 1 (P1), and carried out analysis of cerebellar pathology at progressive time points (Figure 2 ). We show a highly increased incidence of preneoplastic lesions in cerebellum of P1-irradiated compared to unirradiated Ptc1 neo67/ þ mice at 2-3 weeks of age (16/16 versus 10/19; P ¼ 0.0015). With increasing age, the frequency of cerebellar lesions slowly decreased (15/18 at 4-5 weeks; 8/11 at 6-7 weeks), however, remaining constantly higher compared with unirradiated cerebellum (6/17 at 4-5 weeks: P ¼ 0.0059; 5/14 at 6-7 weeks: P ¼ 0.1107). Indeed, a striking difference in incidence of proliferative lesions was observed at 8-9 weeks of age, with 67% (6/9) of irradiated mice still showing cerebellar abnormalities compared with 0% (0/16) unirradiated mice, in which such lesions had undergone complete regression (P ¼ 0.0005). These observations suggest that radiation exposure of Ptc1 cerebellum results in 'de novo' induction of preneoplastic areas, meanwhile strongly facilitating tumor progression.
The incomplete penetrance of tumor formation in mice lacking one Ptc1 copy, and the strong medulloblastoma enhancement by radiation suggests that additional genetic lesions are required for oncogenic transformation. Biallelic Ptc1 loss was recently reported as an early and perhaps initiating event in medulloblastoma tumorigenesis in Ptc1 heterozygous mice (Oliver et al., 2005) , as loss of wt Ptc1 expression was found both in preneoplastic and tumor cells. Thus, additional Ptc1 unrelated events were postulated in the progression of preneoplastic lesions to fully malignant stages. To determine whether biallelic Ptc1 loss represents the causative event in medulloblastoma preneoplasia, we examined Ptc1 loss in laser-capturemicrodissected preneoplastic areas (n ¼ 9) found in unirradiated cerebellum of 2-3 weeks (Figure 3a-e) . We show that in early preneoplasia wt Ptc1 loss is infrequent, occurring only in 1 of 9 (11%) lesions (Figure 4a ), suggesting that modest Shh pathway deregulation associated with Ptc1 heterozygosity is sufficient to sustain abnormal cerebellar proliferation. Importantly, the drastic decrease in frequency of cerebellar abnormalities occurring at later times (Figure 2) suggest that additional genetic events are required for oncogenic transformation of these initial lesions. Our results strongly suggests that the lesions examined by Oliver and co-workers (2005) in 6-weeks old Ptc1 þ /À mouse cerebellum may represent a subset of progressed lesions already committed to full tumor development.
As ionizing radiation facilitates progression of preneoplastic cerebellar lesions (Figure 2) , we screened lesions (n ¼ 26) microdissected from P1-irradiated cerebellum at 2-3 weeks and at later times (4-5 and 6-7 weeks) (Figure 4a ). The frequency of wt Ptc1 loss in Figure 3 Detection of LOH at the Ptc1 locus in preneoplastic lesions. Representative laser-captured section of preneoplasia from unirradiated Ptc1 neo67/ þ mouse cerebellum before (a) and after (b) laser-capture by MMI Cellcut (Molecular Machines and Industries, Switzerland). DNAs from microdissected cerebellar lesions were extracted with PicoPure DNA extraction Kit (Arcturus, CA, USA) and subjected to nested-PCR; primers 8A/9A were used in the first amplification, while primers 8/9 were used in the second round. The DNA fragment obtained (500bp) was purified (Promega) and sequenced. Sequencing reactions were performed by means of dye terminator chemistry using a Big Dye Terminator Vers. Biallelic Ptc1 loss and medulloblastoma progression S Pazzaglia et al preneoplastic areas of irradiated cerebellum was 28.6% (2/7) at 2-3 weeks, and progressively increased to 64% (9/14) in cerebellar lesions microdissected from 4 to 5 weeks old mice, and to 80% (4/5) in lesions from 6 to 7 weeks old mice. Notably, Ptc1 LOH occurred at even higher frequency (over 90%) in full-blown medulloblastomas analysed in this and previous studies. This steadily increasing rate of Ptc1 LOH during medulloblastoma tumorigenesis strongly suggests that this event is involved in tumor progression. Based on the assumption that biallelic Ptc1 loss is the causative event in preneoplasia progression, our finding that at 6-7 weeks 73% of P1-irradiated mice has cerebellar lesions -the large majority of which (80%) with Ptc1 LOH -would imply that at this age 58% of cerebellar lesions must already be committed to frank tumor development. These figures are in good accordance with the 81% medulloblastoma incidence in P1-irradiated mice at 20 weeks of age. Biallelic Ptc1 loss and health decline are also temporally related. In fact, although P1-irradiated Ptc1 neo67/ þ mice appear still healthy at 6-7 weeks of age, they have high incidence of lesions with high malignant potential, and start to manifest severe medulloblastoma symptoms shortly after (8 weeks; Figure 4a) .
Interestingly, comparison of morphologic and molecular characteristics in early (2-3 weeks) spontaneous and radiation-induced cerebellar lesions did not show an obvious association between altered morphological features and Ptc1 LOH. In fact, wt Ptc1 loss was found in low degree abnormalities, such as EGL hyperplasia, while more progressed lesions, such as microtumors, showed wt Ptc1 retention (Figure 4f ). This suggests that, in the cerebellum of Ptc1 mutant mice, Shh pathway activation is per se sufficient to sustain preneoplastic growth leading to EGL abnormalities with different degrees of altered cell morphology. These preneoplastic areas, however, require biallelic Ptc1 loss for tumor progression.
In summary, the data presented here strongly support the importance of biallelic Ptc1 loss in medulloblastoma development in Ptc1 neo67/ þ mice. Based on Ptc1 role as negative regulator of Shh pathway and on the proliferative influence of Shh on CGNPs, such loss may play a fundamental role in progression of medulloblastoma preneoplasia. In addition, the results of analysis of chromosome-13 events in medulloblastomas provide valuable insights into the mechanisms of loss of the normal remaining Ptc1 allele. Finally, our results contribute to clarify the earliest events in medulloblastoma development, and suggest that partial deregulation of Shh pathway -associated with inactivation of one Ptc1 allele -predisposes subpopulations of CGNPs to form subpial aggregates that represent targets of additional Ptc1 mutations and subsequent complete deregulation of Shh pathway that contributes to medulloblastoma development. 
